Live Regional Meetings
RECENT ADVANCES AND EMERGING TRENDS IN ONYCHOMYCOSIS MANAGEMENT: A SERIES OF LIVE CME SATELLITE SYMPOSIA AND AN ENDURING ON-DEMAND WEBINAR
Onychomycosis - a chronic infectious disease with significant medical and psychosocial consequences - can be extremely challenging to eradicate. To manage onychomycosis effectively, clinicians need to understand the etiology, diagnosis, and management of onychomycosis as a chronic infectious disease. They must also understand the characteristics of current topical, systemic, and mechanical treatments and be able to appropriately integrate new and emerging therapies into their practice based on treatment benefits and risks and patient factors. This initiative was designed to educate dermatologic clinicians on recent advances and emerging trends in onychomycosis management based on evidence from clinical trials, data on newer antifungal agents, and expert opinion and recommendations.
ADVANCING THE CARE OF POST-ACNE SCARRING: EXPERT INSIGHTS INTO NEW TREATMENT OPTIONS.
Optimal management of patients with atrophic facial scars of acne vulgaris requires mindfulness of the patient's psychosocial burden; familiarity with the latest evidence-based data on efficacy and safety of available treatment modalities; and the ability to match a patient's skin type, unique scar formation, and desired outcomes with the most appropriate treatment. During this CME-accredited activity, a panel of experts will address barriers to optimal treatment through presentations integrating didactic content with video case studies that include relevant demonstrations of patient assessment and treatment.
TYPE 2 DIABETES MANAGEMENT: CURRENT GUIDELINES AND DECIPHERING THE LATEST THERAPY OPTIONS.
An individualized approach to management of type 2 diabetes mellitus (T2DM) may be the most likely tactic for achieving the best outcomes for any given T2DM patient, but it poses a challenge to clinicians with limited time and resources, especially given the ever-expanding armamentarium of antidiabetic drugs - including the incretin-based classes (GLP-1 receptor agonists and DPP-4 inhibitors), SGLT2 inhibitors, and combination agents. This CME-certified web monograph, which includes faculty audio clips and interactive questions, was designed to help guide appropriate treatment selection based on the T2DM patient's clinical characteristics, therapeutic goals, and patient's preference.
FACIAL AESTHETICS: ADVANCED TECHNIQUES FOR FULL FACE REJUVENATION
This series of CME/CE-certified activities reviews facial anatomy pertinent to full face rejuvenation, discusses the science of soft tissue fillers and neuromodulators, and provides practical information on optimal selection and techniques for these agents based on their characteristics, indications, and efficacy, as well as patient assessment, gender, and goals.
INNOVATIONS IN FACIAL AESTHETIC MEDICINE
This comprehensive CME/CE initiative features experts in aesthetic medicine sharing their insights and expertise on the nuances of treatment based on consistent assessment of facial aging, choice of neuromodulators and soft tissue fillers based on their characteristics, injection technique, and outcome assessment.
INDIVIDUALIZING FACIAL AESTHETIC THERAPY: A FOCUS ON ANATOMIC TARGETING TO OPTIMIZE PATIENT OUTCOMES
This Canadian-based CME/CE initiative, developed for physicians, nurse practitioners, and medical residents/fellows, offered extensive training on noninvasive injectables used in facial aesthetic therapy.
ADVANCES IN COSMETIC THERAPY
The Advances in Cosmetic Therapy series of national CME/CE activities was designed to educate physicians, nurse practitioners, and medical residents/fellows on advances and emerging therapies in facial aesthetics using noninvasive injectable agents.
PRACTICAL TRAINING IN FACIAL AESTHETICS: A COMPREHENSIVE MEDICAL EDUCATION INITIATIVE ON INJECTABLES
This CME/CE-certified initiative was designed to provide physicians, nurse practitioners, and medical residents/fellows with comprehensive training on the spectrum of noninvasive injectables used in facial aesthetic therapy.
STRATEGIES FOR OPTIMAL MANAGEMENT OF ACTINIC KERATOSIS
This series of 10 CME/CE-certified meetings was designed to educate dermatologists and dermatology NPs and PAs on the pathophysiology of AK, evidence-based management and the rationale for combination approaches, moving beyond cryotherapy alone - the current standard of care.
A STEP IN THE RIGHT DIRECTION: OPTIMIZING TREATMENT OUTCOMES IN TINEA PEDIS
This CME/CE/CPE series of meetings provided dermatologists, podiatrists, PAs, NPs, and retail pharmacists with guidance on appropriate use of topical antifungal treatments for tinea pedis, including evidence-based data on traditional and newer antifungal agents and expert strategies for improving patient adherence.
MANAGEMENT OF POST-ACNE SCARRING: ADVANCING THE STANDARD OF CARE
This series of CME meetings for dermatologists, NPs, PAs, and other healthcare professionals who manage atrophic facial scars of acne vulgaris featured experts addressing barriers to optimal care, focusing on benefits of a thorough patient evaluation, evidence-based treatment using new and emerging treatment, and patient-centric principles.
STRATEGIES FOR THE MANAGEMENT OF ACTINIC KERATOSIS
This CME initiative was designed to educate participants on evidence-based management of AK, including the rationale for combination approaches and selection of the most appropriate topical agents based on safety, adherence, and efficacy data from current and ongoing trials.
THE IMPACT OF HYPONATREMIA: ROLE OF THE PHARMACIST IN IMPROVING CARE
This series of regional, live, CPE initiatives was held in conjunction with state and local chapters of national level pharmacy organizations and was co-sponsored by the University of North Carolina Eshelman School of Pharmacy. During each activity, 2 experts in the field of hyponatremia shared important information about the impact of hyponatremia in a presentation enhanced by case studies and discussion.
HOSPITALIST'S ROLE IN OPTIMAL MANAGEMENT OF HYPONATREMIA
This series of live CME meetings, with live webcasts as well as an archived on-demand activity, was designed to help hospitalists optimize management of this condition by facilitating integration of the most current data into practice, so they better understand how historic and newer therapies may fit best within the inpatient treatment paradigm.
HYPONATREMIA: OBSTACLES AND OPPORTUNITIES FOR CLINICAL PHARMACISTS
This series of 10 live CPE symposia was held in conjunction with regional- and state-level meetings of the American College of Clinical Pharmacy, American Society of Health-System Pharmacists and the National Alliance of State Pharmacy Associations. An enduring, interactive, case-based web activity was designed to extend the reach of this important education.
MANAGEMENT OF COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: THE PIVOTAL ROLE OF THE PHARMACIST FROM ADMISSION THROUGH DISCHARGE
Paradigm, in conjunction with UNCESOP, developed and implemented a nationwide CE initiative to meet the educational needs of health-system/clinical pharmacists involved in the care and management of CABP. This series of live meetings held at local-, regional-, and state-level conferences of the major pharmacy organizations (ACCP, ASHP, NASPA) was designed to bridge identified practice gaps in the care of CABP patients.
BENEATH THE SKIN: NEW INSIGHTS INTO BASAL CELL CARCINOMA
This series of live, freestanding, regional CME-certified activities was targeted to a combined multidisciplinary audience of dermatologists, dermatologic surgeons, and medical oncologists and focused on improving diagnosis and management of BCC. The initiative also included a 3-part printed/digital case-based monograph series developed and distributed in conjunction with the Journal of Drugs in Dermatology, a peer-reviewed and MEDLINE-indexed publication that reaches every US-based dermatologist, resident, fellow, PA, and NP in dermatology.
THE MELANOMA CARE COALITION TAKES ON THE CONTROVERSIES
As part of the Melanoma Care Coalition, these regional, live CME-certified activities featured an interactive, case-based approach to complex and often controversial issues in melanoma care. Chaired by Dr. John M. Kirkwood, this series of symposia brought clinical controversies into focus on a practical level for physicians who screen for and treat melanoma. Many of these meetings were held in conjunction with nationally-recognized cancer centers.
TARGETED ORAL ANTICOAGULATION: THE HOSPITALIST'S ROLE IN MANAGING STROKE PREVENTION IN ATRIAL FIBRILLATION
This series of live CME symposia was held in alignment with regular meetings of state/regional chapters of the Society of Hospital Medicine. They focused on the pharmacologic differences among the oral anticoagulants, the evidence for restarting anticoagulant therapy following a major bleeding event in patients with nonvalvular atrial fibrillation, and the importance of the transition of care for patients with nonvalvular AF to both the inpatient and outpatient settings.
CLARIFYING CONCERNS AND CLINICAL CONUNDRUMS: ENSURING APPROPRIATE USE OF TARGET-SPECIFIC ORAL ANTICOAGULANTS
This series of live CPE symposia was held in alignment with meetings of regional-, state-, and local-level chapters of professional pharmacy associations, including the ASHP, the AMCP, and institutional and state pharmacy associations. They focused on validated risk assessment tools to identify patients who may benefit from anticoagulation, selecting the most appropriate agent, and evidence-based strategies to ensure appropriate management of patients on target-specific oral anticoagulants.
ADVANCES IN DIAGNOSIS AND TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)
This live CME symposium was designed to synthesize the burgeoning NSCLC expert knowledge base, with the ultimate goal of facilitating individualized care and improving survival rates for a broader selection of patients. The target audience included thoracic surgeons, surgical oncologists, medical oncologists, radiation oncologists, pulmonologists, GP/IM physicians, and respiratory therapists.